Treatment of Procedural Pain Associated With Turning in Patients With Mechanical Ventilation
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01950000 |
|
Recruitment Status :
Completed
First Posted : September 25, 2013
Last Update Posted : September 30, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Background: Few studies have addressed the situation of procedural pain and the use of preemptive analgesia for turning in patients under mechanical ventilation.
Aim: Evaluation effect of preemptive fentanyl on the incidence of pain during turning maneuvers in critically ill patients under mechanical ventilation.
Design: Single-center clinical trial, national, randomized, double-blind, with a parallel group, and two arms of treatment: saline placebo and fentanyl.
Primary Endpoint: Incidence of pain during the turning procedures that are carried out by nurses measured by means of the Behavioral Pain Scale (BPS).
Study Population: Critically ill patients, age > 18 years, admitted to ICU and expected to require mechanical ventilation for at least 24 h.
Sample Size: 80 patients divided into the two groups (40 patients each). Statistical Analysis: A preliminary descriptive analysis will be carried. Later, results of primary end point will be comparing after the eventual corrections of corresponding variables using a multivariable approach. The AUC variable will be analyzed by a t-test for unpaired data. A second analysis using a multivariate approach will be carried out for those factors considered as clinically relevant in relation to pain and therefore a logistic regression will be used.
Ethical Considerations: The study will be strictly conducted following the Declaration of Helsinki and the protocol and Standard Operating Procedures (SOPs) to ensure compliance with the Good Clinical Practice (GCP) standards. It is the responsibility of the researcher to obtain the valid informed consent from the guardian / legal representative, as the patient's condition will not allow to consent. Before obtaining the consent the investigator will explain to each guardian / legal representative the nature of the study, its purpose, the procedures, the estimated duration, the potential risks and benefits associated with the participation, as well as any inconvenience that this may involve.
Duration of Treatment: The treatment has a maximum duration of 60 min for each patient. The follow-up includes visits and has duration of 6 consecutive days.
Safety Assessment: Potential side effects of treatments will be recorded. Frequent adverse effects of fentanyl administration include respiratory depression, apnea, muscle rigidity, bradycardia and transient hypotension.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Critical Illness Pain | Drug: Fentanyl Other: Placebo | Phase 4 |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 75 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Investigator) |
| Primary Purpose: | Prevention |
| Official Title: | Efficacy and Safety of Opioid Analgesics as a Preventive Treatment of Procedural Pain Associated With Turning Among Critically Ill Patients Under Mechanical Ventilation. A Controlled Clinical Trial Comparing Placebo and Fentanyl |
| Study Start Date : | March 2011 |
| Actual Primary Completion Date : | April 2012 |
| Actual Study Completion Date : | April 2012 |
| Arm | Intervention/treatment |
|---|---|
|
Placebo Comparator: Placebo
Placebo Treatment: A sterile sodium chloride injection 0.9% 10 ml
|
Other: Placebo |
|
Experimental: Fentanest
For this study Fentanest doses were adjusted based on published guidelines from the values recommended media to a whole number and differentiating two groups of patients (multiple trauma / surgical or medical) The maximum dose is 100 mcg Fentanest. The multiple trauma patients / surgical 1.5 mcg / kg and in medical patients 1.0 mcg / kg were given a single bolus Fentanest / Placebo by type of patient (surgical / multiple trauma or physician) 5 'before turning mobilization with personal hygiene. The bolus is given slowly (30'') intravenously, to be preferred by a peripheral without vasoactive drugs (only with fluid therapy). Pharmaceutical form: Sterile solution for injection. Each mL of injectable solution contains the equivalent of 0.05 mg of Fentanest; Excipients: sodium chloride and water for injection. |
Drug: Fentanyl |
- Change in the incidence of pain at the beginning and end of rotation [ Time Frame: Expected average of 5 minutes ]Participants will be evaluated at the beginning and the end of rotation, an expected average of 5 minutes. The evaluation of the change in the incidence of pain will be done calculating the mean between the beginning and the end of rotation.
- Area under the curve (AUC) of incidence of pain (BPS) during mobilizations with spin [ Time Frame: Since the end of the turn until 30 minutes after ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 85 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Subjects must meet all the following criteria:
- Patients that will come with a minimum 24-hour schedule of mechanical ventilation (MV)
- Patients men and women> 18 years and <85 years
- Patients speak and / or understand the Castilian / Catalan
- Patients with hemodynamic and respiratory stability enough, that allows mobilization procedure turn.
- Patients who have a carer / guardian giving consent to participate in the study
Exclusion Criteria:
The subjects presenting one or more of the following criteria are NOT eligible to participate in this study:
- Patients with known hypersensitivity to fentanyl and muscle relaxants
- Patients who are receiving a neuromuscular blocking Neurocritical
- Patients serious (TCE and / or other severe neurological injury (Glasgow <8), increased intracranial pressure, peripheral neuropathy, quadriplegia)
- Patients with brain death or vegetative state
- Patients who have received some extra supplement opioids (morphine, Fentanest) bolus within 4 hours prior to the study.
- Collaboration in the 30 days prior to any study either experimental drugs or devices.
- Patients that potentially present alterations in the ability to understand when they are aware to understand the purpose of the study and to give informed consent in writing.
- Patients undergoing treatment with Monoamine Oxidase Inhibitors
- Women who are pregnant
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01950000
| Spain | |
| Hospital de la Santa Creu i Sant Pau | |
| Barcelona, Spain, 08025 | |
| Study Director: | Ferran Roche-Campo, MD PhD | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | |
| Principal Investigator: | Gemma Robleda, Rn PhD | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
| Responsible Party: | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
| ClinicalTrials.gov Identifier: | NCT01950000 |
| Other Study ID Numbers: |
IRS-FEN-2010-01 |
| First Posted: | September 25, 2013 Key Record Dates |
| Last Update Posted: | September 30, 2013 |
| Last Verified: | September 2013 |
|
Pain. Analgesia. Prevention |
|
Critical Illness Pain, Procedural Disease Attributes Pathologic Processes Pain Neurologic Manifestations Fentanyl Analgesics, Opioid Narcotics |
Central Nervous System Depressants Physiological Effects of Drugs Analgesics Sensory System Agents Peripheral Nervous System Agents Adjuvants, Anesthesia Anesthetics, Intravenous Anesthetics, General Anesthetics |